Quinethazone
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline- 6-sulfonamide |
|
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| CAS number | 73-49-4 |
| ATC code | C03BA02 |
| PubChem | CID 6307 |
| DrugBank | DB01325 |
| ChemSpider | 6068 |
| UNII | 455E0S048W |
| KEGG | D00461 |
| ChEMBL | CHEMBL1532 |
| Chemical data | |
| Formula | C10H12ClN3O3S |
| Mol. mass | 289.739 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Quinethazone (INN, brand name Hydromox) is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.
[edit] Synthesis
[edit] References
Cohen, Elliott; Klarberg, Betty; Vaughan, James R. (1960). Journal of the American Chemical Society 82 (11): 2731. doi:10.1021/ja01496a020.
|
||||||||||||||||||||||||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |